About this trial
The main aim of this clinical trial is to learn about the effect of carbohydrate-rich diet as a treatment for AIP (acute intermittent porphyria).
Aim: Investigate the diet's impact on tissue and serum glucose, plasma insulin, cytokine levels, amino acids, and gut microbiota in AIP, and their correlation with PBG (Porphobilinogen).
Aim: Assess the diet's effect on AIP symptoms and health status in AIP. Aim: Measure the effect of a high-carbohydrate diet on mitochondrial activity in AIP Aim: Map and detect potential mutations in mitochondrial genomic DNA in AIP Aim: Discover new markers in AIP through RNA sequencing and machine learning.
Participants will follow two diet plans, a 4-week intervention with 60-65 E% carbohydrates and a 4 week intervention with 40-45 E% carbohydrates.
Eligibility criteria
Qualifiers
Diagnosis of AIP
Disqualifiers
Not having diagnosis of AIP
Undergoing treatment as part of other clinical research on AIP
Pregnancy
Diabetes
Trial design
Treatments tested in this trial
- Carbohydrates
Treatment groups
Sponsors and collaborators
Nordlandssykehuset HF
Lead sponsor
University of Oslo
Collaborator
Nord University
Collaborator
UiT The Arctic University of Norway
Collaborator
Norwegian University of Science and Technology
Collaborator
The University of Texas Medical Branch, Galveston
Collaborator
Karolinska University Hospital
Collaborator
University Hospital, Umeå
Collaborator